Search
Search Results
##search.searchResults.foundPlural##
-
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
2277PDF: 921HTML: 1661Figure 1: 611 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
895PDF: 593HTML: 4048 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
901PDF: 346Html: 53 -
-
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3060PDF: 1061HTML: 7526 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2511PDF: 817HTML: 2160Untitled: 293Untitled: 201Untitled: 235Untitled: 215Untitled: 233Untitled: 248Untitled: 239 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
975PDF: 584HTML: 261Suppl. Files: 364 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3938PDF: 1392HTML: 2201Fig.1: 300Fig. 2: 286 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2348PDF: 1107HTML: 4123Cover Letter: 286Figure 1: 289Figure 2: 276Table 1: 263 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3601PDF: 640HTML: 738 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2145PDF: 900HTML: 273 -
LIVER IRON CONTENT IN INDIVIDUALS WITH LIVER IRON CONTENT IN INDIVIDUALS WITH Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS.: ROLE OF METABOLIC ALTERATIONS, HFE GENOTYPES, AND CIRRHOSIS. Β-THALASSEMIA TRAIT AND HYPERFERRITINEMIA
371PDF: 376Suppl. Files: 54HTML: 174 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4850PDF: 2082HTML: 18241 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1299PDF: 949HTML: 313 -
-
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1545PDF: 960HTML: 10125cover letter to the editor: 217tile page: 299 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1996PDF: 870HTML: 3703 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2341PDF: 918HTML: 273 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
801PDF: 510HTML: 6296 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1452PDF: 942HTML: 1148Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 232 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
3074PDF: 1437HTML: 189 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3521PDF: 1034HTML: 4982 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7999PDF: 2543HTML: 2180Table 1.: 278Table 2.: 299Table 3.: 271Table 4.: 271 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4253PDF: 1251HTML: 2132Fig.1: 250Fig. 2: 147Table 1: 255Table2: 278Table 3: 263 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2937PDF: 1195HTML: 2703 -
EXERCISE STRESS ECHOCARDIOGRAPHY WITH TISSUE DOPPLER IMAGING (TDI) DETECTS EARLY SYSTOLIC DYSFUNCTION IN BETA-THALASSEMIA MAJOR PATIENTS WITHOUT CARDIAC IRON OVERLOAD
1493PDF: 882HTML: 7897Manuscript after revision: 290Barbero10328-36310-after revision: 290







